A double-blind, placebo-controlled, single-center, randomized, parallel-group clinical trial, the timing of early intervention with Fluticason Furoate for patients with Japanese cedar pollinosis.
Status: Active, no longer recruiting
Phase of Trial: Phase IV
Latest Information Update: 12 May 2016
Price : $35 *
At a glance
- Drugs Fluticasone furoate (Primary)
- Indications Seasonal allergic rhinitis
- Focus Therapeutic Use
- 26 Sep 2015 Status changed from not yet recruiting to active, no longer recruiting, as reported by University Hospital Medical Information Network - Japan record.
- 18 Feb 2014 New trial record